ordinary shares on the Stock Exchange Of Thailand (the “SET”) (“Spin-Off Plan”) will take place after 1) EP has obtained the approval for offering newly issued share from the Office of the Securities and

สารสนเทศข่าว มติ BOD 5-60 Final 20171126 En No. NDR013/2017 Subject Resolution of the Board of Directors’ Meeting To President The Stock Exchange of Thailand Enclosure 1. Information Memorandum on 2

-Translation- Ref. IR 62/005 March 13, 2019 Subject: transaction yDisclosure of the information regarding related part To : President, The Stock Exchange of Thailand T.K.S. Technologies Public

Stock Exchange of Thailand Fortune Parts Industry Public Company Limited (“FPI” or “The Company”) would like to submit the reviewed of interim financial statements for the three-month period ended 30 June

ที่ FPI Ref. FPI.024/2018 12 November 2018 Subject : Management Discussion & Analysis of Performance Results of Quarter 3/2018 To : Board of Directors and President of The Stock Exchange of Thailand

-1- AIT (VP-SEC) 014E/2024 May 9, 2024 Subject: Management's Discussion and Analysis of Operating Results for Q1-2024 To: The President of the Stock Exchange of Thailand Summary of Operations Q1-2024

-1- AIT (VP-SEC) 017E/2024 8 August 2024 Subject: Management's Discussion and Analysis of Operating Results for Q2-2024 To: The President of the Stock Exchange of Thailand Summary of Operations Q1

Extraordinary General Meeting of Shareholders No.1/2019 (EGM 1/2019) To: The President of the Stock Exchange of Thailand Attachment: 1. Information Memorandum of the Purchase and Acquisition of Entire Business

www.interpharma.co.th Inter Pharma Public Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th IP_AC/002/2563 May 11th

Transactions Deemed as Acquisition or Disposal of Assets, dated August 31, 2008 (as amended) and the Notification of the Board of Governors of the Stock Exchange of Thailand regarding Disclosure of Information